Outlook Therapeutics Inc (NASDAQ:OTLK)

2.18
Delayed Data
As of Oct 22
 +0.07 / +3.32%
Today’s Change
0.72
Today|||52-Week Range
4.26
+67.69%
Year-to-Date

Stock Price Forecast

The 3 analysts offering 12-month price forecasts for Outlook Therapeutics Inc have a median target of 7.00, with a high estimate of 8.00 and a low estimate of 6.00. The median estimate represents a +221.10% increase from the last price of 2.18.

Analyst Recommendations

The current consensus among 3 polled investment analysts is to Buy stock in Outlook Therapeutics Inc. This rating has held steady since September, when it was unchanged from a Buy rating.Move your mouse over past
months for detail

 
 
 
 
 
 
 
 

Earnings and Sales Forecasts

Current Quarter

Earnings per Share
-$0.06
Sales
$300.0K
Reporting Date
Dec 22

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly 9.52%
 
 
 
 
 
 
Growthannually 7.80%
 
 
 
 
 
 

Sales

Growthquarterly --
 
 
 
 
 
 
Growthannually --
 
 
 
 
 
 
Key to the earnings and sales forecast charts.